Olema is currently developing a "cancer" drug that suppresses the body's production of Estrogen. Now this could be useful for breast cancer treatment but the real target audience, in my opinion, is hormone replacement therapy for gender transition. I don't necessarily endorse this kind of product but given the corporate and governmental policies surrounding the...
HROW with a nice impulsive, 5-wave move off the low. HROW needs to hold the 0.618 retracement ($18.75) on this pull back, followed by a rally above the $19.95 local peak set today for further confirmation. Very bullish on the long-term prospects of this ticker.
Sunpharma broke out support trendline and retested, ready for more downsides
#SUNPHARMA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
#APOLLOHOSP... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
WOCKPHARMA has completed a long term correction cycle and now could be a good buy with targets above 2,000 in the long term. The invalidation for this analysis remains at 135.20 (marked level).
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.
#CIPLA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
48 PER broken the 14 year trend lchannel also the lower sloping 3 year ( red Channel)
Pfizer may provide a great risk to reward setup. Multi factor trade setup on pfizer likely sees a technical bounce. Keep in mind markets are weak.
going heavy at the pullback for now just a small amount to feel the progress NEURO is GOLDEN
ELOX with its 1.79M float and volume coming in to turn it about 1 time today unless the volume kicks in....Which is still enough to make this move. Good push down to start the day got in at $3.50 Probably if things stay the way they are now then it could go for !.00 from here. Looking for spikes to volume to catch fomo. As I am typing this volume is dragging...
Sanofi - 30d expiry - We look to Buy a break of 88.01 (stop at 84.48) Previous resistance level of 88 broken. Our short term bias remains positive. Previous resistance, now becomes support at 88. 50 1day EMA is at 86.97. Support is located at 88 and should stem dips to this area. Daily signals are mildly bullish. Our profit targets will be 96.72 and 97.72...